Dr. Martens plc

Symbol: DRMTY

PNK

2.05

USD

Market price today

  • 10.4344

    P/E Ratio

  • 0.0312

    PEG Ratio

  • 1.04B

    MRK Cap

  • 0.09%

    DIV Yield

Dr. Martens plc (DRMTY) Financial Statements

On the chart you can see the default numbers in dynamics for Dr. Martens plc (DRMTY). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Dr. Martens plc, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018

balance-sheet.row.cash-and-short-term-investments

0157.5228113.6
117.2
58.4
86.4

balance-sheet.row.short-term-investments

0000
0
0
0

balance-sheet.row.net-receivables

086.391.759.4
68.5
53.1
0

balance-sheet.row.inventory

0257.8123101.5
90
53.9
39.8

balance-sheet.row.other-current-assets

07.20.90.3
1.5
0.1
0

balance-sheet.row.total-current-assets

0508.8443.6274.8
277.2
165.5
169.3

balance-sheet.row.property-plant-equipment-net

0205.4143.8110
114.7
26.9
23.6

balance-sheet.row.goodwill

0240.7240.7240.7
240.7
240.7
240.7

balance-sheet.row.intangible-assets

024.921.420.1
16.5
11.1
7.8

balance-sheet.row.goodwill-and-intangible-assets

0265.6262.1260.8
257.2
251.8
248.5

balance-sheet.row.long-term-investments

01-9.6-7.4
1
0
0

balance-sheet.row.tax-assets

011.89.67.2
7.4
6
4.4

balance-sheet.row.other-non-current-assets

009.67.4
-1
0
0

balance-sheet.row.total-non-current-assets

0483.8415.5378
379.3
284.7
276.5

balance-sheet.row.other-assets

0000
0
0
0

balance-sheet.row.total-assets

0992.6859.1652.8
656.5
450.2
445.8

balance-sheet.row.account-payables

064.252.452.6
33.4
20
19.6

balance-sheet.row.short-term-debt

034.119.818.2
41.8
3.2
4.1

balance-sheet.row.tax-payables

011.66.96.4
3.8
8.3
8.2

balance-sheet.row.long-term-debt-total

0417.7374348.2
140.9
71.1
72.6

Deferred Revenue Non Current

0000
0
5.7
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-

balance-sheet.row.other-current-liab

066.282.881.5
55.5
41.3
31.9

balance-sheet.row.total-non-current-liabilities

0423.9375.9349.8
455.3
394.1
419.6

balance-sheet.row.other-liabilities

0000
0
0
0

balance-sheet.row.capital-lease-obligations

0152.4112.984.8
88.4
0
0

balance-sheet.row.total-liab

0588.4530.9502.1
586
458.6
475.2

balance-sheet.row.preferred-stock

0000
0
0
0

balance-sheet.row.common-stock

0101010
0
0
0

balance-sheet.row.retained-earnings

01782.21711.31538.1
224.7
170.1
-43.6

balance-sheet.row.accumulated-other-comprehensive-income-loss

0126.92.6
-154.2
-178.5
0

balance-sheet.row.other-total-stockholders-equity

0-1400-1400-1400
0
0
14.2

balance-sheet.row.total-stockholders-equity

0404.2328.2150.7
70.5
-8.4
-29.4

balance-sheet.row.total-liabilities-and-stockholders-equity

0992.6859.1652.8
656.5
450.2
445.8

balance-sheet.row.minority-interest

0000
0
0
0

balance-sheet.row.total-equity

0404.2328.2150.7
70.5
-8.4
-29.4

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-

Total Investments

01-9.6-7.4
1
0
0

balance-sheet.row.total-debt

0451.8393.8366.4
182.7
74.3
76.7

balance-sheet.row.net-debt

0294.3165.8252.8
65.5
15.9
-9.7

Cash Flow Statement

The financial landscape of Dr. Martens plc has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM202320222021202020192018

cash-flows.row.net-income

0128.9181.274.8
74.8
17.2
-5.7

cash-flows.row.depreciation-and-amortization

054.236.929.5
29.5
10.6
6.5

cash-flows.row.deferred-income-tax

022.8-11.3-18.9
0
0
0

cash-flows.row.stock-based-compensation

00.55.211.5
0
0
0

cash-flows.row.change-in-working-capital

0-145.9-42.6-17
-17
-12.4
10.1

cash-flows.row.account-receivables

0-6.6-23.30.8
-16.6
-10
0

cash-flows.row.inventory

0-133.2-18.3-36.1
-36.1
-14.1
9.2

cash-flows.row.account-payables

0-6.1-151.2
35.7
11.7
0

cash-flows.row.other-working-capital

000-32.9
0
0
0.9

cash-flows.row.other-non-cash-items

016.81541.5
34.1
40.6
35.1

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-51.4-25-21.9
-21.9
-17.1
-16.4

cash-flows.row.acquisitions-net

0-100
0
0
0

cash-flows.row.purchases-of-investments

0-100
0
0
0

cash-flows.row.sales-maturities-of-investments

012.800
0
0
0

cash-flows.row.other-investing-activites

0-1000
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

0-50.6-25-21.9
-21.9
-17.1
-16.4

cash-flows.row.debt-repayment

000-92.7
-3.2
-14.1
-4

cash-flows.row.common-stock-issued

00037.8
0
0
0

cash-flows.row.common-stock-repurchased

000-35
-35
-60
0

cash-flows.row.dividends-paid

0-58.4-12.20
0
0
0

cash-flows.row.other-financing-activites

0-41.1-34.845.9
-5.8
4.8
-5.3

cash-flows.row.net-cash-used-provided-by-financing-activities

0-99.5-47-44
-44
-69.3
-9.3

cash-flows.row.effect-of-forex-changes-on-cash

02.323.3
3.3
2.4
-1.1

cash-flows.row.net-change-in-cash

0-70.5114.458.8
58.8
-28
19.2

cash-flows.row.cash-at-end-of-period

0157.5228117.2
117.2
58.4
86.4

cash-flows.row.cash-at-beginning-of-period

0228113.658.4
58.4
86.4
67.2

cash-flows.row.operating-cash-flow

077.3184.4121.4
121.4
56
46

cash-flows.row.capital-expenditure

0-51.4-25-21.9
-21.9
-17.1
-16.4

cash-flows.row.free-cash-flow

025.9159.499.5
99.5
38.9
29.6

Income Statement Row

Dr. Martens plc's revenue saw a change of NaN% compared with the previous period. The gross profit of DRMTY is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM202320222021202020192018

income-statement-row.row.total-revenue

01000.3908.3773
672.2
454.4
348.6

income-statement-row.row.cost-of-revenue

0382.2329.5302.5
270.7
193.8
162.6

income-statement-row.row.gross-profit

0618.1578.8470.5
401.5
260.6
186

income-statement-row.row.gross-profit-ratio

0000
0
0
0

income-statement-row.row.research-development

0---
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-

income-statement-row.row.other-expenses

0000
0
0
0

income-statement-row.row.operating-expenses

0427.3352.7281.3
259
192.6
145.8

income-statement-row.row.cost-and-expenses

0809.5682.2583.8
529.7
386.4
308.4

income-statement-row.row.interest-income

01.90.10
0
0
0

income-statement-row.row.interest-expense

017.513.838.7
40.7
38.3
38.8

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-

income-statement-row.row.total-other-income-expensenet

0-21.4-13.8-41.6
-41.5
-39.1
-39.5

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-

income-statement-row.row.other-operating-expenses

0000
0
0
0

income-statement-row.row.total-operating-expenses

0-21.4-13.8-41.6
-41.5
-39.1
-39.5

income-statement-row.row.interest-expense

017.513.838.7
40.7
38.3
38.8

income-statement-row.row.depreciation-and-amortization

054.236.929.5
29.5
10.6
6.5

income-statement-row.row.ebitda-caps

0---
-
-
-

income-statement-row.row.operating-income

0180.8228.1112.5
142.5
68
40.2

income-statement-row.row.income-before-tax

0159.4214.370.9
101
28.9
0.7

income-statement-row.row.income-tax-expense

030.533.135.2
26.2
11.7
6.4

income-statement-row.row.net-income

0128.9181.234.7
74.8
17.2
-5.7

Frequently Asked Question

What is Dr. Martens plc (DRMTY) total assets?

Dr. Martens plc (DRMTY) total assets is 992600000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.582.

What is company free cash flow?

The free cash flow is 0.036.

What is enterprise net profit margin?

The net profit margin is 0.106.

What is firm total revenue?

The total revenue is 0.169.

What is Dr. Martens plc (DRMTY) net profit (net income)?

The net profit (net income) is 128900000.000.

What is firm total debt?

The total debt is 451800000.000.

What is operating expences number?

The operating expences are 427300000.000.

What is company cash figure?

Enretprise cash is 0.000.